Skip to content

YP Face IT: Assessing the feasibility, acceptability and potential effectiveness of an online psychotherapeutic intervention for adolescents with visible differences that suffer from appearance related problems.

YP Face IT: Assessing the feasibility, acceptability and potential effectiveness of an online psychotherapeutic intervention for adolescents with visible differences that suffer from appearance related problems. - YP Face IT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON46518
Enrollment
224
Registered
2018-06-22
Start date
2018-07-17
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

zichtbare aandoeningen appearance-related distress Visible differences

Interventions

YP Face IT is an online psychotherapeutic intervention. The sessions contain elements of social skilss interaction training and cognitive behavioural therapy, and is aimed at improving adolescents'

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
12 Years to 17 Years

Inclusion criteria

Inclusion criteria: Aged 12-18 with a visible difference; Parental permission under the age of 16; Have access to a computer with internet; Phase 2: Experience problems in the areas of social anxiety, depressive symptoms or body esteem (only for RCT).

Exclusion criteria

Exclusion criteria: Mental disability; Reading ability below 12 years of age; Visual impairments preventing comprehension of the online intervention; Diagnosis of depression, psychosis, body dysmorphic disorder or eating disorder; Insufficient proficiency in Dutch by parent or adolescent Phase 2: receiving face-to-face treatment.

Design outcomes

Primary

MeasureTime frame
For the different project phases: 1) acceptability and feasibility: acceptability for Dutch adolescents and the extent to which it meets their needs. 2) RCT: social anxiety and body esteem.

Secondary

MeasureTime frame
Phase 1: Social anxiety and body esteem. Phase 1 and 2: Aspects of self-worth, perceived stigmatization, quality of life, body dysmorphic disorder symptoms, depressive symptoms, demographic variables and information on the visible difference.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)